Conditions Galvus Treats
Galvus is used to treat type2 diabetes. Type 2 diabetes develops when the body is unable to produce enough insulin. Deficiency of insulin results in an inability of the body to metabolize sugars. This in turn causes the accumulation of sugars in the blood, causing diabetes or high blood sugar levels. In some cases of type 2 diabetes, the body produces enough insulin but the insulin does not work well enough. Sometimes, excess glucagon production also results in type 2 diabetes. Glucagon can increase sugar production by the liver and cause high blood sugar in cases where insulin production or action is insufficient. While some cases of type 2 diabetes can be managed with some dietary modifications and a good exercise regimen, some other cases may require the use of medications to control sugar levels. Galvus belongs to a class of medications called dipeptidyl peptidase-4 inhibitors. Incretin hormones called glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) help control sugar levels in the body. These hormones work by stimulating the pancreas to release more insulin and also inhibit the production of glucagon. Dipeptidyl peptidase-4 enzyme breaks down these hormones in the body. By binding to dipeptidyl peptidase-4 and inhibiting its action, Galvus helps increase the levels of GLP-1 and GIP and thus reduces blood sugar levels. |
|
Galvus General InformationGalvus is a medication that is used for the control of type 2 diabetes. This medication is manufactured by Novartis. The active ingredient is vildagliptin. Its chemical name is (S)-1-[N-(3-hydroxy-1-adamantyl) glycyl] pyrrolidine-2-carbonitrile. Its molecular formula is C17H25N3O2 and it has a molecular weight of 303.399 g/mol.
|
|

